193 related articles for article (PubMed ID: 30014595)
1. Carboplatin and vincristine neurotoxicity in the treatment of pediatric low-grade gliomas.
Rosca L; Robert-Boire V; Delisle JF; Samson Y; Perreault S
Pediatr Blood Cancer; 2018 Nov; 65(11):e27351. PubMed ID: 30014595
[TBL] [Abstract][Full Text] [Related]
2. Single agent carboplatin for pediatric low-grade glioma: A retrospective analysis shows equivalent efficacy to multiagent chemotherapy.
Dodgshun AJ; Maixner WJ; Heath JA; Sullivan MJ; Hansford JR
Int J Cancer; 2016 Jan; 138(2):481-8. PubMed ID: 26235348
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
Scheinemann K; Bartels U; Tsangaris E; Hawkins C; Huang A; Dirks P; Fried I; Bouffet E; Tabori U
Pediatr Blood Cancer; 2011 Jul; 57(1):84-8. PubMed ID: 21557457
[TBL] [Abstract][Full Text] [Related]
4. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy -- report from the multicenter treatment study for children and adolescents with a low grade glioma -- HIT-LGG 1996 -- of the Society of Pediatric Oncology and Hematology (GPOH).
Gnekow AK; Kortmann RD; Pietsch T; Emser A
Klin Padiatr; 2004; 216(6):331-42. PubMed ID: 15565548
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of combination carboplatin and vinblastine for pediatric low-grade glioma.
Nellan A; Wright E; Campbell K; Davies KD; Donson AM; Amani V; Judd A; Hemenway MS; Raybin J; Foreman NK; Rush S; Dorris K
J Neurooncol; 2020 Jul; 148(3):569-575. PubMed ID: 32506370
[TBL] [Abstract][Full Text] [Related]
6. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
[TBL] [Abstract][Full Text] [Related]
7. [HIT-LGG: effectiveness of carboplatin-vincristine in progressive low-grade gliomas of childhood--an interim report].
Gnekow AK; Kaatsch P; Kortmann R; Wiestler OD
Klin Padiatr; 2000; 212(4):177-84. PubMed ID: 10994547
[TBL] [Abstract][Full Text] [Related]
8. A pilot study using carboplatin, vincristine, and temozolomide in children with progressive/symptomatic low-grade glioma: a Children's Oncology Group study†.
Chintagumpala M; Eckel SP; Krailo M; Morris M; Adesina A; Packer R; Lau C; Gajjar A
Neuro Oncol; 2015 Aug; 17(8):1132-8. PubMed ID: 25854526
[TBL] [Abstract][Full Text] [Related]
9. A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.
Gnekow AK; Walker DA; Kandels D; Picton S; Giorgio Perilongo ; Grill J; Stokland T; Sandstrom PE; Warmuth-Metz M; Pietsch T; Giangaspero F; Schmidt R; Faldum A; Kilmartin D; De Paoli A; De Salvo GL;
Eur J Cancer; 2017 Aug; 81():206-225. PubMed ID: 28649001
[TBL] [Abstract][Full Text] [Related]
10. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.
Packer RJ; Ater J; Allen J; Phillips P; Geyer R; Nicholson HS; Jakacki R; Kurczynski E; Needle M; Finlay J; Reaman G; Boyett JM
J Neurosurg; 1997 May; 86(5):747-54. PubMed ID: 9126887
[TBL] [Abstract][Full Text] [Related]
11. Current Salvage Treatment Strategies for Younger Children (<10 y of Age) With Progressive Low-grade Glioma After Initial Chemotherapy in North America: A Web-based Survey.
Moorman B; Barbour M; Huang MA
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e141-e145. PubMed ID: 33235141
[TBL] [Abstract][Full Text] [Related]
12. Tolerance of nitrosurea-based multiagent chemotherapy regime for low-grade pediatric gliomas.
Lancaster DL; Hoddes JA; Michalski A
J Neurooncol; 2003 Jul; 63(3):289-94. PubMed ID: 12892235
[TBL] [Abstract][Full Text] [Related]
13. Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: report from the HIT-LGG 1996 trial.
von Hornstein S; Kortmann RD; Pietsch T; Emser A; Warmuth-Metz M; Soerensen N; Straeter R; Graf N; Thieme B; Gnekow AK
Pediatr Blood Cancer; 2011 Jul; 56(7):1046-54. PubMed ID: 21319282
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma.
Paulino AC; Mazloom A; Terashima K; Su J; Adesina AM; Okcu MF; Teh BS; Chintagumpala M
Cancer; 2013 Jul; 119(14):2654-9. PubMed ID: 23633429
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.
Packer RJ; Lange B; Ater J; Nicholson HS; Allen J; Walker R; Prados M; Jakacki R; Reaman G; Needles MN
J Clin Oncol; 1993 May; 11(5):850-6. PubMed ID: 8487049
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen.
Prados MD; Edwards MS; Rabbitt J; Lamborn K; Davis RL; Levin VA
J Neurooncol; 1997 May; 32(3):235-41. PubMed ID: 9049885
[TBL] [Abstract][Full Text] [Related]
17. Temozolomide in pediatric low-grade glioma.
Khaw SL; Coleman LT; Downie PA; Heath JA; Ashley DM
Pediatr Blood Cancer; 2007 Nov; 49(6):808-11. PubMed ID: 17588234
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience.
Heath JA; Turner CD; Poussaint TY; Scott RM; Goumnerova L; Kieran MW
Pediatr Hematol Oncol; 2003; 20(7):497-504. PubMed ID: 12959854
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.
Dodgshun AJ; Hansford JR; Cole T; Choo S; Sullivan MJ
Pediatr Blood Cancer; 2016 Jan; 63(1):17-20. PubMed ID: 26207610
[TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolone prophylaxis does not increase risk of neuropathy in children with acute lymphoblastic leukemia.
Karol SE; Sun Y; Tang L; Pui CH; Ferrolino J; Allison KJ; Cross SJ; Evans WE; Crews KR; Jeha S; Wolf J
Cancer Med; 2020 Sep; 9(18):6550-6555. PubMed ID: 32710497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]